GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Short-Term Capital Lease Obligation

AP Biosciences (ROCO:6945) Short-Term Capital Lease Obligation : NT$11.65 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Short-Term Capital Lease Obligation?

AP Biosciences's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$11.65 Mil.

AP Biosciences's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (NT$11.65 Mil) to Jun. 2024 (NT$11.65 Mil) but then declined from Jun. 2024 (NT$11.65 Mil) to Dec. 2024 (NT$11.65 Mil).

AP Biosciences's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (NT$0.00 Mil) to Dec. 2023 (NT$11.65 Mil) but then stayed the same from Dec. 2023 (NT$11.65 Mil) to Dec. 2024 (NT$11.65 Mil).

AP Biosciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for AP Biosciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Short-Term Capital Lease Obligation Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Capital Lease Obligation
- - - 11.65 11.65

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial - 9.54 11.65 11.65 11.65

AP Biosciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

AP Biosciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
ROCO:06891 ROCO:3176 ROCO:6808 ROCO:4178 ROCO:1777 TPE:6838 TPE:6794 ROCO:8279 ROCO:6733 ROCO:6634 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
Website
https://www.apbioinc.com
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines